Polee, M B <br/><br/>
Phase II study of neo-adjuvant chemotherapy with paclitaxel and cisplatin given every 2 weeks for patients with a resectable squamous cell carcinoma of the esophagus.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Aug 2003 
 - 1253-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0923-7534 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdg328  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Squamous Cell--drug therapy<br/>Chemotherapy, Adjuvant<br/>Cisplatin--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Esophageal Neoplasms--drug therapy<br/>Esophagectomy--methods<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Neoplasm Staging<br/>Paclitaxel--administration & dosage<br/>Probability<br/>Prognosis<br/>Survival Analysis<br/>Treatment Outcome